Chicago Research Rally: New Directions in Glomerular Disease
New Directions in Glomerular Disease
Palmer House Hilton
17 East Monroe Street
Chicago, IL 60603
October 25, 2019
Activity Overview This CME event is dedicated to knowledge sharing around rare protein-spilling kidney diseases (glomerular diseases) and clinical trials. This Rally will help further clinical practice in an area that contains large knowledge and performance gaps. Without a forum, a large gap develops between the research and the day to day care of patients. The result is an uneven quality of care and missed opportunities for patients to gain access to new treatments and clinical trials. Sessions will detail the complexities of treating glomerular disease patients, the wide variations of patient reactions to treatment, prevention strategies, and the optimal management of care. Expert faculty will present the most current research issues and practice recommendations to support clinicians and providers in the care of patients with glomerular diseases. Additionally, nephrology has lagged in the coordination and execution of clinical trials and a session will be devoted to educating attendees about interventional research.
Other allied healthcare professionals
Suneel Udani, MD
Nephrology Associates of Northern Illinois and Indiana (NANI)
Patrick Cunningham, MD
Jochen Reiser, MD, PhD
Cybele Ghossein, MD
Northwestern Feinberg School of Medicine
Vasil Peev, MD
Shikha Wadhwani, MD, MS
Pravir V. Baxi, MD
*******PATIENTS AND HCPs in SAME SESSION*******
8:30 am Welcome and Panel Introduction
8:45-9:15 am Patient Storytelling
9:15-9:45 am Importance of Disease registries for rare renal diseases
(Ambarish Athavale, MBBS, MD - Cook County Hospital)
9:45-10:30 am Translational Nephrology (Jochen Reiser, MD, PhD - Rush)
10:30-10:45 am Break
10:45-11:15 am Updates on Lupus Nephritis Management (Samir Parikh, MD - Ohio State University)
11:15 am-12:00 pm Transitioning from Pediatric to Adult (Cybele Ghossein, MD - Northwestern)
12:00 pm-12:30 pm Proteinuria reduction as a surrogate outcome for renal disease progression-implications for drug approval (George Bakris, MD- University of Chicago)
Participants must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. NOTE: If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Accreditation Statement - This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Amedco and NephCure Kidney International. Amedco is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
Amedco designates this live activity for a maximum of TBD AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgement of Sponsors
NephCure Kidney International gratefully acknowledges Retrophin, Inc. as a sponsor of this activity.
QUESTIONS? Contact: Rebecca Cook at (610) 540-0186 ext. 20 or at firstname.lastname@example.org for more information about this event.
October 25, 2019
Palmer House Hilton: 17 East Monroe Street, Chicago, IL 60603